|
Interesting how healthcare costs get boiled down to big Pharma so fast.
The realities of the pharmaceutical industry are a bit different than you all seem to think. First and foremost is the cost of developing, getting approval for, and marketing the drugs are enormous, then throw in the liability that goes along with their production and the inevitable lawsuits when they're used, add to that the countless countries who put price caps on the drugs and what you've got is a recipe for a market where very potential drugs will be pursued and brought to fruition.
As it stands, the US market is subsidizing the Canadian and European drug markets because it's one of the few major markets that doesn't impose price controls. Should the US go that route, you will see a whole lot fewer new drugs coming out into any market.
__________________
Strive to be more curious than ignorant.
|